Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis - Wikidata - awgldk - TriplyDB

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis

http://www.wikidata.org/entity/Q36752026

about

Nutrition and Hepatocellular Cancer Clinical relevance of sarcopenia in patients with cirrhosis.Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.Role of Nutrition and Muscle in Cirrhosis.Sarcopenia from mechanism to diagnosis and treatment in liver disease.The utility of pulmonary function testing in predicting outcomes following liver transplantation.A multicenter study to define sarcopenia in patients with end-stage liver disease.Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality.Hepatic encephalopathy: Ever closer to its big bang.The MELD-Plus: A generalizable prediction risk score in cirrhosis.Liver Transplantation in the Obese Cirrhotic Patient.Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C.Nutrition and the transplant candidate.A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation.[Functional MR imaging of the liver].Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease

P2860

Q26741102-DE53300D-D926-4B9E-BCAD-5C7AAEE95DA1 Q33845474-185C6AD7-F2B3-4536-AB61-087645ED1643 Q35819511-3254B4FA-5AC4-49D3-AD05-FE847F0DF4B8 Q38712435-EA0BE33F-295A-4FC2-B225-0EDE3B55D42B Q38723591-05A953FF-84CC-4E37-B682-F1392BAA0EB1 Q38792500-EADAB163-2D5B-4EE9-9CF2-7910788F3CD2 Q38925372-BCDB34D6-78E5-4C52-9657-2930871EF09A Q39957982-38409A2A-A015-478B-9C86-EED6019CBEC9 Q40316947-53B2BB53-8D0A-4DBC-ADD3-90FD04BF0CC8 Q40405220-2B091F4C-D378-4DAF-8097-DAA6BCCEFA19 Q42337444-D07B98C7-C2F2-48BE-9F07-E2E8D5563EC4 Q42369220-26F9A70E-E8CC-445D-8852-19F554516610 Q45963039-E15046D3-9C57-472E-9B21-4CA3B976C3A2 Q46569927-DBEC17A3-FE47-4918-A57C-6657617F8D6D Q47551529-F166DB57-67F7-4FE8-93CE-88F0835113A1 Q47600945-8C30A401-08DC-4AB9-BB94-CB41EB0B0520 Q48090027-D1AA72EC-BA04-470B-AB18-B8CE5DFA6696 Q48130444-62127E0A-3D05-4D46-9492-DCCDECF3553A Q48198814-3019AE11-2190-4F08-954A-1FC7F0C159D7 Q52931158-E8A2AD8E-811B-4B8E-B41D-229974BC02DC Q52987727-1D239824-65F0-4D48-88E7-A0C8DFC51713 Q55263120-8BE6B6FC-3B2E-4F5B-89D9-E9B4DA952252 Q58773148-8C59E613-9279-4DBF-8553-764BF44D4F8D

P2860

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis

http://www.wikidata.org/entity/Q36752026

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Inclusion of Sarcopenia Within ...... ity in Patients With Cirrhosis

@en

type

label

Inclusion of Sarcopenia Within ...... ity in Patients With Cirrhosis

@en

prefLabel

Inclusion of Sarcopenia Within ...... ity in Patients With Cirrhosis

@en

P1433

Q36752026-DFC821B4-74F0-4DB4-976F-2913E587AE5C

P1476

Q36752026-454EF416-3BD7-4676-9C0E-1DC2BDAA1315

P2093

Q36752026-03234E12-FC1B-470C-A869-AC233F3C7338

Q36752026-8E95BBE4-0B1F-4B30-8786-948BB4035B46

Q36752026-90CB9CF1-AAD3-413C-8CD5-925BEF48BF6B

Q36752026-AA53D5EC-43C2-469C-8F8E-AD484C7FDD32

Q36752026-C05E6C26-1F69-4E24-A3C6-4EBADA03C9B0

Q36752026-E090D600-2931-45D3-991A-420C09B708D7

Q36752026-F39566FE-0FDC-49CB-B7EC-6B5150D9F8AD

Q36752026-FBBDD36A-EFDC-4C23-B4D7-B0D9F9E5DC4F

P2860

Q36752026-134EB411-5BAC-4C3A-89C9-3F40AEAC7C5D

Q36752026-2484DCFB-5062-485B-81B3-C7AF1B8F7F9F

Q36752026-29BE1802-40E4-4B72-9942-D23A84F6FE3F

Q36752026-2E8C92F3-5B2D-4681-A25E-AAC019B1F846

Q36752026-39673607-95D5-4A38-B054-2F20ACDD6DA5

Q36752026-404B27AB-3AAD-4ED3-9A6F-378AFB16A014

Q36752026-41DBC502-346F-4B04-B1E7-84DFB887A4C7

Q36752026-43A1A6E0-472A-41AE-9924-CE71CDC2EFA7

Q36752026-489424E6-0F85-469B-8AB4-22220023AC21

Q36752026-4BFC0DCD-13D1-4E9C-AC8F-01DC988BAD0C

P2888

Q36752026-116E35D5-E346-4215-8A65-FBB5D18BF11D

P304

Q36752026-3DBD677F-4762-4611-818F-064FD2340306

P31

Q36752026-3661C125-3057-4CA6-AFE6-9BD0D6BC9A75

P356

Q36752026-6D58DC4C-AE1E-4717-ACC4-65DE94EE80C3

P478

Q36752026-EF725D7E-FABF-4A60-93FF-EE708D67F5FD

P50

Q36752026-ABCE9A4E-E04B-4887-8AA4-734C5D6F5B48

P577

Q36752026-EA31EDD7-34AE-4361-8744-3B674E5A262E

P5875

Q36752026-4BFE13FB-6A30-45B8-81B0-E1DF27562315

P6179

Q36752026-1F0D6608-E0BF-4AA1-847F-0A2DB4A27411

P698

Q36752026-24CC5578-C7B9-41B5-AE67-B7C4AAB7E8D8

P932

Q36752026-6F3D8CCA-BE67-4E93-A738-B94316743D88

P356

P1433

Clinical and translational gastroenterology

P1476

Inclusion of Sarcopenia Within ...... ity in Patients With Cirrhosis

@en

P2093

Andres Duarte-Rojo

http://www.w3.org/2001/XMLSchema#string

Crystal Beaumont

http://www.w3.org/2001/XMLSchema#string

Jack X Q Pang

http://www.w3.org/2001/XMLSchema#string

Judith Meza-Junco

http://www.w3.org/2001/XMLSchema#string

Michael B Sawyer

http://www.w3.org/2001/XMLSchema#string

Nina Esfandiari

http://www.w3.org/2001/XMLSchema#string

Robert P Myers

http://www.w3.org/2001/XMLSchema#string

Vickie E Baracos

http://www.w3.org/2001/XMLSchema#string

P2860

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

Epidemiology of sarcopenia among the elderly in New Mexico

Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Sarcopenia and mortality after liver transplantation.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.

Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.

The new liver allocation system: moving toward evidence-based transplantation policy.

Hyponatremia and mortality among patients on the liver-transplant waiting list

Consilience in sarcopenia of cirrhosis.

P2888

P304

e102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CTG.2015.31

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Aldo J Montano-Loza

P577

2015-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281822300

http://www.w3.org/2001/XMLSchema#string

P6179

1019263832

http://www.w3.org/2001/XMLSchema#string

P698

26181291

http://www.w3.org/2001/XMLSchema#string

P932

4816259

http://www.w3.org/2001/XMLSchema#string